Literature DB >> 14961976

Induction of cystic forms by different stress conditions in Borrelia burgdorferi.

R Murgia1, M Cinco.   

Abstract

Cystic forms of Borrelia burgdorferi might represent a low metabolic activity state or phase of B. burgdorferi cells that allows the spirochete to survive in a hostile environment until conditions are favourable to multiply again. In this study we evaluated the rate of cyst formation induced by oxidative stress, pH variations, and heating, reconversion of cysts to vegetative forms, and some aspects of their metabolic activity. We observed cyst formation in the presence of extreme pH values, and at high temperature, but the best production of cystic forms was observed in the presence of H2O2. When transferred to BSK II medium, the cystic forms reconverted to spirochetes in relation to their age and type of induction treatment. Furthermore, we demonstrated a low metabolic activity of cystic forms by measuring amino acid incorporation. Overall, these data suggest that the phenomenon of conversion to cysts by B. burgdorferi provides a limited survival potential. This short-term survival, however, gives borreliae an additional chance to overcome unfavourable environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14961976     DOI: 10.1111/j.1600-0463.2004.apm1120110.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  31 in total

Review 1.  ppGpp conjures bacterial virulence.

Authors:  Zachary D Dalebroux; Sarah L Svensson; Erin C Gaynor; Michele S Swanson
Journal:  Microbiol Mol Biol Rev       Date:  2010-06       Impact factor: 11.056

Review 2.  The anti-borreliae efficacy of phytochemicals and micronutrients: an update.

Authors:  Anna Goc; Matthias Rath
Journal:  Ther Adv Infect Dis       Date:  2016-07-04

Review 3.  A systematic review of Borrelia burgdorferi morphologic variants does not support a role in chronic Lyme disease.

Authors:  Paul M Lantos; Paul G Auwaerter; Gary P Wormser
Journal:  Clin Infect Dis       Date:  2013-12-12       Impact factor: 9.079

4.  Efficacy of Short-Term High Dose Pulsed Dapsone Combination Therapy in the Treatment of Chronic Lyme Disease/Post-Treatment Lyme Disease Syndrome (PTLDS) and Associated Co-Infections: A Report of Three Cases and Literature Review.

Authors:  Richard I Horowitz; Phyllis R Freeman
Journal:  Antibiotics (Basel)       Date:  2022-07-07

5.  A Comparative Study of Body Lice and Bed Bugs Reveals Factors Potentially Involved in Differential Vector Competence for the Relapsing Fever Spirochete Borrelia recurrentis.

Authors:  Rashaun Potts; Jamie L Scholl; Lee A Baugh; Jose E Pietri
Journal:  Infect Immun       Date:  2022-04-06       Impact factor: 3.609

Review 6.  Lyme Disease Frontiers: Reconciling Borrelia Biology and Clinical Conundrums.

Authors:  Vladimir V Bamm; Jordan T Ko; Iain L Mainprize; Victoria P Sanderson; Melanie K B Wills
Journal:  Pathogens       Date:  2019-12-16

7.  Lyme disease: the next decade.

Authors:  Raphael B Stricker; Lorraine Johnson
Journal:  Infect Drug Resist       Date:  2011-01-07       Impact factor: 4.003

8.  Evaluation of in-vitro antibiotic susceptibility of different morphological forms of Borrelia burgdorferi.

Authors:  Eva Sapi; Navroop Kaur; Samuel Anyanwu; David F Luecke; Akshita Datar; Seema Patel; Michael Rossi; Raphael B Stricker
Journal:  Infect Drug Resist       Date:  2011-05-03       Impact factor: 4.003

Review 9.  Borreliella burgdorferi Antimicrobial-Tolerant Persistence in Lyme Disease and Posttreatment Lyme Disease Syndromes.

Authors:  Felipe C Cabello; Monica E Embers; Stuart A Newman; Henry P Godfrey
Journal:  mBio       Date:  2022-04-25       Impact factor: 7.786

10.  Characterization of biofilm formation by Borrelia burgdorferi in vitro.

Authors:  Eva Sapi; Scott L Bastian; Cedric M Mpoy; Shernea Scott; Amy Rattelle; Namrata Pabbati; Akhila Poruri; Divya Burugu; Priyanka A S Theophilus; Truc V Pham; Akshita Datar; Navroop K Dhaliwal; Alan MacDonald; Michael J Rossi; Saion K Sinha; David F Luecke
Journal:  PLoS One       Date:  2012-10-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.